Correlation Between United Guardian and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both United Guardian and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining United Guardian and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between United Guardian and Carmell Therapeutics, you can compare the effects of market volatilities on United Guardian and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in United Guardian with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of United Guardian and Carmell Therapeutics.
Diversification Opportunities for United Guardian and Carmell Therapeutics
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between United and Carmell is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding United Guardian and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and United Guardian is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on United Guardian are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of United Guardian i.e., United Guardian and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between United Guardian and Carmell Therapeutics
Allowing for the 90-day total investment horizon United Guardian is expected to generate 0.07 times more return on investment than Carmell Therapeutics. However, United Guardian is 13.55 times less risky than Carmell Therapeutics. It trades about -0.01 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about -0.3 per unit of risk. If you would invest 993.00 in United Guardian on September 14, 2024 and sell it today you would lose (11.00) from holding United Guardian or give up 1.11% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 38.1% |
| Values | Daily Returns |
United Guardian vs. Carmell Therapeutics
Performance |
| Timeline |
| United Guardian |
| Carmell Therapeutics |
United Guardian and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with United Guardian and Carmell Therapeutics
The main advantage of trading using opposite United Guardian and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if United Guardian position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.| United Guardian vs. Utah Medical Products | United Guardian vs. Union Bankshares | United Guardian vs. Psychemedics | United Guardian vs. Unity Bancorp |
| Carmell Therapeutics vs. Ryanair Holdings PLC | Carmell Therapeutics vs. BJs Restaurants | Carmell Therapeutics vs. Dine Brands Global | Carmell Therapeutics vs. United Guardian |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |